Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium

INTRODUCTION: As integrase inhibitors become available in low‐ and middle‐income countries (LMICs), they offer the potential to expand extremely limited treatment options available to children and adolescents. In LMICs, only small numbers have used raltegravir, primarily as part of third‐line regime...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Int AIDS Soc
Päätekijät: Patten, Gabriela, Puthanakit, Thanyawee, McGowan, Catherine C, Wools‐Kaloustian, Kara, Hazra, Rohan, Pinto, Jorge A, Machado, Daisy, Succi, Regina, Sohn, Annette H, Rabie, Helena, Musick, Beverly, Davies, Mary‐Ann
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Short Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7387110/
https://ncbi.nlm.nih.gov/pubmed/32722897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jia2.25580
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia